铊-201 的体外放射性毒性概念验证研究
本研究在乳腺癌 MDA-MB-231 与前列腺癌 DU145 细胞中评估俄歇电子发射体铊-201(201Tl)的体外动力学与放射性毒性。结果显示 201Tl 仅在进入细胞后才显著降低克隆形成并增加核 DNA 损伤,提示其用于靶向分子放射性核素治疗的潜力。
要点
- 201Tl 细胞内摄取在 90 分钟内达平衡,换液后呈指数洗脱(t1/2 15 分钟)。
- 仅内化的 201Tl 降低克隆形成并增加 DNA 损伤,被高钾缓冲液排除在细胞外时无显著毒性。
- 达到 90% 克隆形成抑制的细胞内平均活度约为 DU145 0.29 Bq/细胞、MDA-MB-231 0.18 Bq/细胞(90 分钟暴露)。
核心结论
- 201Tl 仅在进入细胞后才降低克隆形成存活并增加核 DNA 损伤。
- 这些发现支持进一步开发与评估 201Tl 治疗性放射性药物。
研究设计与样本
- 体外细胞研究,使用乳腺癌 MDA-MB-231 与前列腺癌 DU145 细胞系。
- 细胞与 200–8000 kBq/mL [201Tl]TlCl 孵育,钾浓度 0–25 mM 调节摄取。
- 采用伽马计数测摄取与洗脱、克隆形成实验评估存活、γH2AX 荧光成像测核 DNA 损伤。
主要发现
- 两种细胞系的 201Tl 摄取均在 90 分钟内达平衡,换液后呈指数洗脱(t1/2 15 分钟)。
- DU145 细胞摄取率在 1.6%(25 mM 钾)至 25.9%(0 mM 钾)之间。
- 随细胞内 201Tl 活度增加,两种细胞系的集落形成显著减少;高钾缓冲液将 201Tl 排除在细胞外时无显著毒性。
- 相同浓度的非放射性 TlCl 无毒性。
- 90 分钟暴露期间细胞内平均活度约 0.29 Bq/细胞(DU145)和 0.18 Bq/细胞(MDA-MB-231)时,克隆形成减少 90%。
临床怎么用
- 提示 201Tl 作为俄歇电子发射体用于靶向治疗时,需确保被靶细胞内化才能产生放射性毒性。
局限性
- 研究仅为体外概念验证,尚未在体内或临床中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Auger electron-emitting radionuclides have potential in targeted treatment of small tumors. Thallium-201 (201Tl), a gamma-emitting radionuclide used in myocardial perfusion scintigraphy, decays by electron capture, releasing around 37 Auger and Coster-Kronig electrons per decay. However, its therapeutic and toxic effects in cancer cells remain largely unexplored. Here, we assess 201Tl in vitro kinetics, radiotoxicity and potential for targeted molecular radionuclide therapy, and aim to test the hypothesis that 201Tl is radiotoxic only when internalized. METHODS: Breast cancer MDA-MB-231 and prostate cancer DU145 cells were incubated with 200-8000 kBq/mL [201Tl]TlCl. Potassium concentration varied between 0 and 25 mM to modulate cellular uptake of 201Tl. Cell uptake and efflux rates of 201Tl were measured by gamma counting. Clonogenic assays were used to assess cell survival after 90 min incubation with 201Tl. Nuclear DNA damage was measured with γH2AX fluorescence imaging. Controls included untreated cells and cells treated with decayed [201Tl]TlCl. RESULTS: 201Tl uptake in both cell lines reached equilibrium within 90 min and washed out exponentially (t1/2 15 min) after the radioactive medium was exchanged for fresh medium. Cellular uptake of 201Tl in DU145 cells ranged between 1.6 (25 mM potassium) and 25.9% (0 mM potassium). Colony formation by both cell lines decreased significantly as 201Tl activity in cells increased, whereas 201Tl excluded from cells by use of high potassium buffer caused no significant toxicity. Non-radioactive TlCl at comparable concentrations caused no toxicity. An estimated average 201Tl intracellular activity of 0.29 Bq/cell (DU145 cells) and 0.18 Bq/cell (MDA-MB-231 cells) during 90 min exposure time caused 90% reduction in clonogenicity. 201Tl at these levels caused on average 3.5-4.6 times more DNA damage per nucleus than control treatments. CONCLUSIONS: 201Tl reduces clonogenic survival and increases nuclear DNA damage only when internalized. These findings justify further development and evaluation of 201Tl therapeutic radiopharmaceuticals.
引用
- Osytek KM, Blower PJ, Costa IM, et al. In vitro proof of concept studies of radiotoxicity from Auger electron-emitter thallium-201. EJNMMI Res. 2021. PMID: 34224019. doi:10.1186/s13550-021-00802-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。